CK

Chiranjeevi Kamireddy

Active Director Additional Director DIN 11336429
DIN 11336429 First appointment Oct 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Chiranjeevi Kamireddy

Data last updated:

Chiranjeevi Kamireddy is an Additional Director at Octum Life Sciences Private Limited (since 2025). The company operates in Pharma.

DIN 11336429
Primary Designation Additional Director
Industry Pharma
First Appointment 10 Oct 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Octum Life Sciences Private Limited U24299AP2020PTC116063
Additional Director10 Oct 2025Active

Board colleagues of Chiranjeevi Kamireddy

Directorship timeline

Open interactive timeline →
Octum Life Sciences Private Limited
Premium access

Shareholding and investment profile for Chiranjeevi Kamireddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chiranjeevi Kamireddy

Chiranjeevi Kamireddy currently holds 1 directorship: Octum Life Sciences Private Limited (Additional Director, since 10 Oct 2025).

Chiranjeevi Kamireddy was first appointed on 10 Oct 2025 as Additional Director at Octum Life Sciences Private Limited.

The current boards of Chiranjeevi Kamireddy's companies include Kamireddy Suresh (Octum Life Sciences Private Limited), Ravi Kumar Duvvuru (Octum Life Sciences Private Limited), Vikas Nagareddy (Octum Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available